Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01770405 · ClinicalTrials.gov registry record
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
A clinical trial of Pancreatic Cancer and Pancreatic Neoplasms, sponsored by Mauna Kea Technologies.
- Completed
- Registry status
- 40
- Enrollment target
- 4
- Study locations
NCT01770405 is a study of Pancreatic Cancer and Pancreatic Neoplasms that has completed, run by Mauna Kea Technologies. The registered enrollment target is 40 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT01770405, a study of Pancreatic Cancer and Pancreatic Neoplasms, has completed, sponsored by Mauna Kea Technologies.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study focuses on four different lesions: pancreatic cysts, lymph nodes near the gastrointestinal tract, pancreatic masses and GIST tumors. On one hand, the results obtained during previous studies are more advanced for the assessment of the diagnostic performance of Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system for Pancreatic cysts. Safety and technical feasibility have already been performed, and an interpretation criteria classification exists. On the other hand, results for pancreatic masses, Lymph nodes and GIST are less developed. the objectives of the study are to * Assess the diagnostic performance of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in diagnosing masses and cystic tumors of the pancreas, lymph nodes, submucosal lesions of the GI tract * Define/Validate descriptive criteria of nCLE sequences in masses and cystic tu-mors of the pancreas, lymph nodes, submucosal lesions of the GI tract
Conditions Studied
Interventions
- DEVICE Endoscopic ultrasound fine needle aspiration
Study Locations (4)
New York
- North Shore-LIJ Health System - Manhasset
- Columbia University Medical Center - New York
Georgia
- Emory University Hospital - Atlanta
Pennsylvania
- Temple University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-12-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01770405
The ClinicalTrials.gov registry entry for NCT01770405 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Mauna Kea Technologies, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic ultrasound fine needle aspiration is the first listed.
NCT01770405 reports 4 study locations spanning 3 distinct geographic areas - top geographies include New York, Georgia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01770405 about?
NCT01770405 is a clinical study titled "Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract". This study focuses on four different lesions: pancreatic cysts, lymph nodes near the gastrointestinal tract, pancreatic masses and GIST tumors. On one hand, the results obtained during previous studies are more advanced for the assessment of the diagnostic performance of Cellvizio needle-based Conf...
What is the current status of trial NCT01770405?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-09. Estimated completion is 2016-12-21.
What conditions does trial NCT01770405 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Neoplasms, Pancreatic Cyst, GIST, Lymphadenopathy.
What interventions are being tested in trial NCT01770405?
The interventions under investigation include: Endoscopic ultrasound fine needle aspiration (DEVICE).
Who is sponsoring clinical trial NCT01770405?
This trial is sponsored by Mauna Kea Technologies, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01770405 being conducted?
This trial has 4 study locations across Georgia, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.